Summary
The provided FDA label text includes indications, contraindications (MTC/MEN 2), and thyroid C-cell tumor warnings, but does not include any information needed to verify storage, temperature allowances, shelf life/expiration statements, protection from light/freezing, or carton/pen storage timelines. Therefore most claims are unsupported by the supplied label excerpt.
Category Scores
Accurate Statements
ZEPBOUND is contraindicated in patients with a personal or family history of MTC or MEN 2.
Label Section 4 (CONTRAINDICATIONS).
ZEPBOUND causes thyroid C-cell tumors in rats and human relevance is unknown.
Label Section 5.1 (Risk of Thyroid C-Cell Tumors).
Unsupported Statements
Zepbound has a shelf life of 36 months.
No shelf life/expiration-duration information is present in the supplied label text.
Unopened packages of Zepbound should not be used beyond 36 months.
No guidance on shelf life or use beyond a specific number of months is present in the supplied label text.
Using Zepbound after its expiration date is not recommended.
No expiration-date handling language is present in the supplied label text.
Expired Zepbound may have decreased potency and effectiveness over time.
No statement about potency/effectiveness changes after expiration is present in the supplied label text.
The expiration date for Zepbound is printed on both the carton and the pen label.
No labeling/where expiration date is printed is present in the supplied label text.
Zepbound should be stored at room temperature between 68°F and 77°F (20°C to 25°C).
No storage temperature ranges are present in the supplied label text.
Zepbound can be stored for a short time between 59°F and 86°F (15°C and 30°C).
No storage excursion/short-time temperature range is present in the supplied label text.
Zepbound should be protected from light.
No light-protection storage instruction is present in the supplied label text.
Zepbound should be protected from freezing.
No freezing-protection storage instruction is present in the supplied label text.
Improper storage conditions, such as exposure to extreme temperatures, could compromise Zepbound stability and shelf life.
No stability/shelf-life impact from improper storage is present in the supplied label text.
Before use, unopened Zepbound pens should be stored in their original carton to protect them from light.
No pre-use storage-in-carton/light protection guidance is present in the supplied label text.
Once an opened carton is removed from the refrigerator or its original packaging, it must be used within 36 months or by the expiration date, whichever comes first.
No opened-carton timeline or refrigerator/original packaging removal instructions are present in the supplied label text.
Unopened Zepbound pens can be stored in the refrigerator or at room temperature.
No refrigerator-vs-room-temperature storage option is present in the supplied label text.
After an opened carton of Zepbound is removed from its original packaging, it should be used within 36 months or by the expiration date, whichever comes first.
No opened carton/removed-from-original-packaging instruction is present in the supplied label text.
Opened cartons of Zepbound should not be frozen.
No opened-carton freezing instruction is present in the supplied label text.
Contradictions
Important Omissions
Storage and handling, shelf life/expiration, and product disposal/use instructions were not provided in the supplied label excerpt, so the AI claims about these topics cannot be verified against the provided FDA-approved text.
Importance:
High
Safety Assessment
Potential Patient Risk:
Medium
Several claims concern storage/expiration use timing and could affect product handling. Because the supplied label text does not contain these details, compliance with the label cannot be confirmed.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Misaligned
Primary Issue
Most storage/shelf-life/expiration-related claims are not supported by the provided label excerpt; only the contraindication and thyroid C-cell tumor warning claims align with the supplied text.
Suggested Improvement
Limit the response to prescribing-information content present in the provided excerpt (Section 4 and Section 5.1). For storage/handling and expiration/shelf life claims, use and cite the specific FDA label sections/lines that contain those details.